MedPath

SWINBURNE UNIVERSITY OF TECHNOLOGY

SWINBURNE UNIVERSITY OF TECHNOLOGY logo
🇦🇺Australia
Ownership
Private
Established
1908-01-01
Employees
1K
Market Cap
-
Website
http://www.swin.edu.au

Clinical Trials

76

Active:1
Completed:34

Trial Phases

5 Phases

Phase 1:4
Phase 2:11
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (72 trials with phase data)• Click on a phase to view related trials

Not Applicable
48 (66.7%)
Phase 2
11 (15.3%)
Phase 4
6 (8.3%)
Phase 1
4 (5.6%)
Phase 3
3 (4.2%)

Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices

Not Applicable
Recruiting
Conditions
Auditory Hallucination
Schizophrenia and Related Disorders
Psychotic Disorders
First Posted Date
2023-08-08
Last Posted Date
2024-11-22
Lead Sponsor
Swinburne University of Technology
Target Recruit Count
212
Registration Number
NCT05982158
Locations
🇦🇺

Swinburne University of Technology, Hawthorn, Victoria, Australia

Exercise Rehabilitation for Hip-related Pain and Dysfunction in Student Circus Arts Performers

Not Applicable
Recruiting
Conditions
Hip Dysplasia
Femoro Acetabular Impingement
First Posted Date
2023-01-18
Last Posted Date
2023-05-12
Lead Sponsor
Swinburne University of Technology
Target Recruit Count
20
Registration Number
NCT05687955
Locations
🇦🇺

Swinburne University of Technology, Hawthorn, Victoria, Australia

Effects of Normobaric Hypoxia and Different Exercise Modes on Blood Glucose Regulation in Overweight Adults

Not Applicable
Completed
Conditions
Healthy
Physical Inactivity
Overweight
First Posted Date
2022-11-28
Last Posted Date
2023-11-22
Lead Sponsor
Swinburne University of Technology
Target Recruit Count
13
Registration Number
NCT05627804
Locations
🇲🇾

National Sports Institute of Malaysia, Kuala Lumpur, Malaysia

The Potential of a Low Oxygen Environmental Chamber as an Aid to Exercise Training to Improve Metabolic Health

Not Applicable
Completed
Conditions
Physical Inactivity
Overweight
Healthy
First Posted Date
2022-10-13
Last Posted Date
2022-10-13
Lead Sponsor
Swinburne University of Technology
Target Recruit Count
14
Registration Number
NCT05577429
Locations
🇲🇾

National Sports Institute of Malaysia, Kuala Lumpur, Malaysia

Evaluation of the Nextdoor KIND Challenge

Not Applicable
Completed
Conditions
Loneliness
Social Isolation
First Posted Date
2020-05-21
Last Posted Date
2021-04-23
Lead Sponsor
Swinburne University of Technology
Target Recruit Count
4500
Registration Number
NCT04398472
Locations
🇦🇺

Swinburne University of Technology, Hawthorn, Australia

  • Prev
  • 1
  • 2
  • Next

News

Swinburne University and Tryptamine Therapeutics Launch World-First Intravenous Psilocin Trial for Binge Eating Disorder

Tryptamine Therapeutics and Swinburne University have signed an agreement to conduct the world's first clinical trial using intravenous psilocin (TRP-8803) to treat Binge Eating Disorder, with recruitment beginning this quarter.

© Copyright 2025. All Rights Reserved by MedPath